Ritholtz Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.5M | Buy |
49,487
+1,552
| +3% | +$334K | 0.19% | 66 |
|
|
2026
Q1 | $10.4M | Buy |
47,935
+487
| +1% | +$108K | 0.18% | 68 |
|
|
2025
Q4 | $10.8M | Buy |
47,448
+3,723
| +9% | +$848K | 0.2% | 57 |
|
|
2025
Q3 | $10.1M | Buy |
43,725
+2,113
| +5% | +$430K | 0.2% | 58 |
|
|
2025
Q2 | $7.72M | Buy |
41,612
+1,877
| +5% | +$349K | 0.17% | 69 |
|
|
2025
Q1 | $8.33M | Buy |
39,735
+1,433
| +4% | +$279K | 0.25% | 56 |
|
|
2024
Q4 | $6.81M | Buy |
38,302
+245
| +0.6% | +$45K | 0.2% | 63 |
|
|
2024
Q3 | $7.52M | Sell |
38,057
-804
| -2% | -$150K | 0.23% | 57 |
|
|
2024
Q2 | $6.67M | Sell |
38,861
-327
| -0.8% | -$54.2K | 0.22% | 58 |
|
|
2024
Q1 | $7.14M | Buy |
39,188
+2,817
| +8% | +$485K | 0.25% | 53 |
|
|
2023
Q4 | $5.64M | Sell |
36,371
-3,986
| -10% | -$581K | 0.22% | 54 |
|
|
2023
Q3 | $6.02M | Buy |
40,357
+5,800
| +17% | +$851K | 0.27% | 50 |
|
|
2023
Q2 | $4.66M | Sell |
34,557
-7,612
| -18% | -$1.12M | 0.21% | 62 |
|
|
2023
Q1 | $6.72M | Buy |
42,169
+1,610
| +4% | +$246K | 0.34% | 39 |
|
|
2022
Q4 | $6.55M | Sell |
40,559
-10,660
| -21% | -$1.63M | 0.37% | 39 |
|
|
2022
Q3 | $6.87M | Buy |
51,219
+13,193
| +35% | +$1.89M | 0.37% | 29 |
|
|
2022
Q2 | $5.82M | Sell |
38,026
-6,819
| -15% | -$1.04M | 0.37% | 24 |
|
|
2022
Q1 | $7.27M | Buy |
44,845
+33,021
| +279% | +$4.8M | 0.49% | 27 |
|
|
2021
Q4 | $1.6M | Buy |
11,824
+2,083
| +21% | +$246K | 0.1% | 102 |
|
|
2021
Q3 | $1.05M | Sell |
9,741
-205
| -2% | -$23.4K | 0.07% | 133 |
|
|
2021
Q2 | $1.12M | Buy |
9,946
+215
| +2% | +$24.2K | 0.08% | 121 |
|
|
2021
Q1 | $1.05M | Buy |
9,731
+2,565
| +36% | +$274K | 0.09% | 106 |
|
|
2020
Q4 | $768K | Buy |
7,166
+2,330
| +48% | +$224K | 0.07% | 114 |
|
|
2020
Q3 | $424K | Buy |
4,836
+830
| +21% | +$78.1K | 0.05% | 158 |
|
|
2020
Q2 | $393K | Buy |
+4,006
| New | +$353K | 0.05% | 139 |
|
|
2020
Q1 | – | Sell |
-6,691
| Closed | -$592K | – | 179 |
|
|
2019
Q4 | $592K | Buy |
6,691
+867
| +15% | +$72K | 0.09% | 75 |
|
|
2019
Q3 | $441K | Buy |
5,824
+353
| +6% | +$24.2K | 0.07% | 80 |
|
|
2019
Q2 | $398K | Buy |
5,471
+173
| +3% | +$13.6K | 0.07% | 85 |
|
|
2019
Q1 | $427K | Sell |
5,298
-190
| -3% | -$15.5K | 0.08% | 82 |
|
|
2018
Q4 | $506K | Buy |
5,488
+413
| +8% | +$36.3K | 0.11% | 62 |
|
|
2018
Q3 | $480K | Buy |
5,075
+227
| +5% | +$21.5K | 0.12% | 63 |
|
|
2018
Q2 | $449K | Buy |
4,848
+130
| +3% | +$12.7K | 0.12% | 64 |
|
|
2018
Q1 | $447K | Sell |
4,718
-232
| -5% | -$25.5K | 0.13% | 62 |
|
|
2017
Q4 | $479K | Buy |
+4,950
| New | +$467K | 0.14% | 69 |
|
Other funds holding ABBV
Ritholtz Wealth Management's ABBV Position: Q2 2026 in Review
Ritholtz Wealth Management increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $334K and bringing the position to 49,487 shares worth $12.5M. The position accounts for 0.19% of the portfolio, ranked #66.
Ritholtz Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Ritholtz Wealth Management held 49,487 shares of AbbVie worth $12.5M as of Q2 2026.
- Ritholtz Wealth Management bought 1,552 AbbVie shares in Q2 2026, an estimated $334K.
- AbbVie made up 0.19% of Ritholtz Wealth Management's portfolio in Q2 2026, its #66 holding.
- Ritholtz Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Ritholtz Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.